On the other hand, numerous studies have reported that gliomas have specific molecular parameters, such as IDH-mutation (Chen et al., 2017; Kesler et al., 2019) and MGMT promoter methylation (Chen et al., 2017). This evidence concerns the gene MGMT and central nervous system cancer.